This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints, Permissions and Rights Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by KRIEGER, D. T. Search for Related Content PubMed PubMed Citation Articles by KRIEGER, D. T.

Physiopathology of Cushing's Disease

Mount Sinai School of Medicine New York, New York 10029

Abstract

HARVEY CUSHING first described a patient with the disease bearing his name in 1912 (1). The patient manifested rapidly acquired central obesity, hypertrichosis, amenorrhea, and muscle weakness; on physical examination, "her round face was dusky and cyanoid," supraclavicular and posterior cervical fat pads were present, and it was also noted that the skin was rough and dry, with considerable pigmentation, and with numerous ecchymoses and purplish striae. At that time, Cushing was uncertain as to whether the symptoms were attributable to pituitary "or adrenal, pineal, or ovarian influences," involvement of these regions having previously been reported in association with similar clinical findings. There was apparently an even earlier report of a similar clinical syndrome by Osier in 1899 (2), which was described, however, as "An acute myxoedematous condition, with tachycardia, glycosuria, melaena, mania, and death" (the latter occurring within 6 months of onset). Between 1923 and 1926, in addition to other case reports, there were three in which similar signs and symptoms were described in association with pituitary tumors, which the authors considered to be incidental findings (3–5).

This article has been cited by other articles:

				G. D. Hammer, J. B. Tyrrell, K. R. Lamborn, C. B. Applebury, E. T. Hannegan, S. Bell, R. Rahl, A. Lu, and C. B. Wilson Transsphenoidal Microsurgery for Cushing's Disease: Initial Outcome and Long-Term Results J. Clin. Endocrinol. Metab., December 1, 2004; 89(12): 6348 - 6357. [Abstract] [Full Text] [PDF]

				P. L. M. Dahia and A. B. Grossman The Molecular Pathogenesis of Corticotroph Tumors Endocr. Rev., April 1, 1999; 20(2): 136 - 155. [Abstract] [Full Text]

				S. L. Asa and S. Ezzat The Cytogenesis and Pathogenesis of Pituitary Adenomas Endocr. Rev., December 1, 1998; 19(6): 798 - 827. [Abstract] [Full Text]

				N. A. T. M. Huizenga, P. de Lange, J. W. Koper, R. N. Clayton, W. E. Farrell, A. J. van der Lely, A. O. Brinkmann, F. H. de Jong, and S. W. J. Lamberts Human Adrenocorticotropin-Secreting Pituitary Adenomas Show Frequent Loss of Heterozygosity at the Glucocorticoid Receptor Gene Locus J. Clin. Endocrinol. Metab., March 1, 1998; 83(3): 917 - 921. [Abstract] [Full Text]

				A. H. Tahir and L. R. Sheeler Recurrent Cushing's Disease After Transsphenoidal Surgery Arch Intern Med, May 1, 1992; 152(5): 977 - 981. [Abstract] [PDF]

				G. Dickstein, A. Spindel, C. Shechner, F. Adawi, and H. Gutman Spontaneous Remission in Cushing's Disease Arch Intern Med, January 1, 1991; 151(1): 185 - 189. [Abstract] [PDF]

				M. Heinrichs, W. Baumgartner, and C. C. Capen Immunocytochemical Demonstration of Proopiomelanocortin-derived Peptides in Pituitary Adenomas of the Pars Intermedia in Horses Veterinary Pathology, November 1, 1990; 27(6): 419 - 425. [Abstract] [PDF]

				M. Cappa, E. Stoner, J. DiMartino-Nardi, S. Pang, J. Temeck, and M. I. New Recurrence of Cushing's Disease in Childhood After Radiotherapy-Induced Remission Arch Pediatr Adolesc Med, July 1, 1987; 141(7): 736 - 740. [Abstract] [PDF]

				W. M. Burch Cushing's Disease: A Review Arch Intern Med, June 1, 1985; 145(6): 1106 - 1111. [Abstract] [PDF]